Journals / Medicine Science / 2014 / Cilt: 3 - Sayı: 2

Comparison between Nitazoxanide and Metronidazole in the Treatment of Protozoal Diarrhea in Children

Pages
1162–1173
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A 3-day course of nitazoxanide could replace much longer regimens of metronidazole

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diarrheal disease is a leading cause of illness and death in children worldwide.
📊
Key Findings & Data:This study was carried out on 160 diarrheic patients (83 males and 77 females), aged from 1-11 years old collected from the-clinics of pediatric department at Beni suef University Hospital.
💡
Conclusion & Impact:A 3-day course of nitazoxanide could replace much longer regimens of metronidazole
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diarrheal disease is a leading cause of illness and death in children worldwide. Diarrhea is caused by a blend of bacterial, viral and parasitic pathogens. Enteric protozoal infections such as giardiasis, amebiasis and cryptosporidiosis are among the most common and most prevalent forms of gastrointestinal parasitic infections worldwide. Both nitazoxanide and metronidazole are used in treatment of protozoal diarrhea. Nitazoxanide was found to have a very broad spectrum of activity against many forms of parasites. Metronidazole also produces good results when it is used for treatment of parasitic infections. The aim in this study was to evaluate and compare the effect of nitazoxanide and metronidazole in treatment of protozoal diarrhea in children. This study was carried out on 160 diarrheic patients (83 males and 77 females), aged from 1-11 years old collected from the-clinics of pediatric department at Beni suef University Hospital. Patients were divided into two groups. Group A received Nitazoxanide 100 mg in 1-4 years aged patients and 200 mg in 4-11 years aged patients twice daily for 3 days respectively, Group B received Metronidazole 50 mg/Kg/body weight daily for 7 days. Patients were represented to full history taking, physical examination, laboratory investigations in the form of stool analysis, culture and complete blood count (CBC). There was a significant increase in the number of cases resolved by Nitazoxanide compared to Metronidazole group in both amebiasis and giardiasis (p-value < 0.05) with similar clinical improvement when using Nitazoxanide for 3 days and Metronidazole for 7 days. This study confirms the efficacy and safety of nitazoxanide as a 3-day treatment of diarrhea due to giardiasis & amebiasis in children. A 3-day course of nitazoxanide could replace much longer regimens of metronidazole

🔖

Cite This Article

ALİ, A. A. E., ABDELRAHİM, M. E., ELMOSLAMY, N. A., SAİD, A. S. A., MEABED, M. H. (2014). Comparison between Nitazoxanide and Metronidazole in the Treatment of Protozoal Diarrhea in Children. Medicine Science, Cilt: 3 - Sayı: 2, 1162–1173. https://ajindex.com/articles/273095

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Niehaus MD, Moore SR, Patrick PD, Derr LL, Lorntz B, Lima AA, Guerrant RL. Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. Am J Trop Med Hyg. 2002; 66(5):590-593
  2. Farthing M J. Diarrhea: a significant worldwide problem. Int j antimicrob Agents. 2000;14(1):65-9
  3. Roy CC, Silverman A, Alagille D. Diarrheal Disorders. Pediatric Clinical Gastroenterology. 4th ed. Mosby-year book. St. Louis. 1995;216-34
  4. Bhan MK, Bhandari N, Bhatnagar S, Bahi R. epidemiology and management of persistent diarrhea in children of developing countries. Indian J Med Res. 1996; 18:103-114
  5. Schiller LR. Diarrheal disease. Med Clinic North Am. 2000; 84(5):1259-74
  6. Ono K, Rai SK, Chikahira M, Fujimoto T, Shibata H, Wada Y, Tsuji H, Oda Y, Rai G, Shrestha CD, Masuda K, Shrestha HG, Matsumura T, Hotta H, Kawamura T, Uga S. Seasonal distribution of enteropathogens detected from diarrheal stool and water samples collected in Kathmandu, Nepal. Southeast Asian J Trop Med public Health. 2001;32(3):520-526
  7. Checkley W, Epstein LD, Gilman RH, Cabrera L, Black RE. Effects of acute diarrhea on linear growth in Peruvian children. Am J Epidermiol. 2003; 157(2):166-175
  8. Ochoa TJ, White AC Jr. Nitazoxanide for the treatment of intestinal parasite in children. Pediatr Infect Dis J. 2005; 24(7): 641-42
  9. Abdel-Rahman MS, El-Bahy MM, El-Bahy NM. Testing the parasiticidal efficacy of nitazoxanide. Alex J Vet Sci. 1997; 13:447–58
  10. Micromedex T. Drug Information for the Health Care Professional. Greenwood Village CO. 2006;1:2069
  11. Bowman WC, Rand MJ. Treatment of Trichomonas urogenitalis. Textbook of Pharmacology. 2nd ed. Blackwell Scientific Publications. 1980;36:16
  12. Kosek M, Bern C, Guerrant RL. The global burden of diarrheal disease as estimated from studies published between 1992 and 2000. Bull World Health Organ. 2003; 81(3):197-204
  13. Mathan VI. Diarrheal diseases. Br Med Bull. 1998;54 (2):407-419
  14. Land KM, Johnson PJ. Molecular basis of metronidazole resistance in pathogenic bacteria and protozoa. Drug Resist Updat. 1999; 2:289–94
  15. Diniz CG, Santos SG, Pestana AC, Farias LM, Carvalho MA, Auxiliadora M. Chromosomal breakage in the B. fragilis group induced by metronidazole treatment. Anaerobe. 2000;6(3):149–53
  16. Speich B, Marti H, Ame SM, Ali SM, Bogoch II, Utzinger J, Albonico M, Keiser J. Prevalence of intestinal protozoa infection among school-aged children